EFFICACY BENEFIT WITH EVEROLIMUS AND VERY LOW TACROLIMUS EXPOSURE IN DE NOVO RENAL TRANSPLANT RECIPIENTS: 12 MONTH RESULTS OF THE ASSET STUDY | Publicación